LINC01517

Across TCGA pan-cancer cohorts, LINC01517 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of LINC01517’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01517 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01517 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, KIRP, and KICH are the cancer types where LINC01517 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01517 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	−0.254	<.001	8	view →
KIRP	All	II,III,IV	−0.451	<.001	6	view →
KICH	All	All	−0.385	<.001	6	view →
COAD	Male	IV	−0.046	<.001	4	view →
CHOL	All	All	+0.062	.001	3	view →
LIHC	Male	All	+0.058	.041	2	view →
BLCA	All	All	+0.019	.038	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

LINC01517–KIRC

Open the KIRC breakdown →